Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Huan Jing Ke Xue ; 39(7): 3452-3459, 2018 Jul 08.
Artículo en Chino | MEDLINE | ID: mdl-29962173

RESUMEN

The direct application of fresh compost is frequent in practice and might cause odor pollution. The present study investigated the characteristics of odor emissions and aimed to estimate the environmental effect of odor over the course of storage and application. An odors emission potential test lasting 21 days was conducted using primarily fermented fruit and vegetable waste compost. The results showed that the fresh compost primarily emitted ammonia, as well as sulfur compounds, benzenes, and terpenes throughout the experiment. Alcohol and aldehyde emissions decreased over time, whereas ketone emissions were consistently low. By simulating two scenarios-one in an enclosed space and one in open air-the quantity of fresh compost could be applied or stored, and the protective distance was calculated from the point of odor potential.


Asunto(s)
Contaminantes Atmosféricos/análisis , Compostaje , Odorantes/análisis , Monitoreo del Ambiente
2.
Artículo en Inglés | MEDLINE | ID: mdl-22658465

RESUMEN

The aim of this study was to develop a rapid and sensitive method for the simultaneous quantification of metronidazole (MEZ), tinidazole (TNZ), ornidazole (ONZ) and morinidazole (MNZ) in human saliva. A reversed-phase high-performance liquid chromatography (HPLC) method with ultraviolet (UV) detection at 318 nm was carried out on a C18 column, using a mixture of potassium dihydrogen phosphate buffer, acetonitrile, and methanol (55:15:30, v/v/v) as a mobile phase with a flow rate of 1.0 ml/min. The saliva samples (100 µl) were firstly deproteinized by precipitation with methanol (400 µl), after which they were centrifuged and the supernatants were directly injected into the HPLC system. This method produced linear responses in the concentration ranges of 25.2-5040.0, 23.9-4790.0, 25.4-5080.0, 25.0-5000.0 ng/ml with detection limits of 6.0, 17.6, 10.0 and 11.3 ng/ml for MEZ, TNZ, ONZ and MNZ (S/N=3), respectively. The methods were validated in terms of intra- and inter-batch precision (within 7.3% and 9.1%, respectively), accuracy, linearity, recovery and stability. The study proved that HPLC is both sensitive and selective for the simultaneous quantification of MEZ, TNZ, ONZ and MNZ in human saliva using a single mobile phase.


Asunto(s)
Antibacterianos/análisis , Cromatografía Líquida de Alta Presión/métodos , Metronidazol/análisis , Nitroimidazoles/análisis , Ornidazol/análisis , Saliva/química , Tinidazol/análisis , Antibacterianos/uso terapéutico , Femenino , Humanos , Masculino , Metronidazol/uso terapéutico , Nitroimidazoles/uso terapéutico , Ornidazol/uso terapéutico , Penicilina G Benzatina , Enfermedades Periodontales/tratamiento farmacológico , Sensibilidad y Especificidad , Tinidazol/uso terapéutico
3.
Clin Drug Investig ; 32(4): 247-52, 2012 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-22299715

RESUMEN

BACKGROUND: Bismuthyl ecabet is a combination of sulfodehydroabietic acid and bismuth, which forms a new type of salt that is useful in treating peptic ulcers and gastritis. OBJECTIVE: This study was designed to assess the safety and tolerability of bismuthyl ecabet suspension in healthy Chinese subjects. METHODS: For the study 77 volunteers were randomized into single- or multiple-dose groups for oral administration of bismuthyl ecabet 200-1600 mg once daily or 1200 mg twice daily for 7 days. Safety and tolerability were assessed by adverse events, physical examination and serum biochemistry. RESULTS: In both the single- and multiple-dose studies, no severe adverse events were observed in any of the volunteers. The main adverse events caused by the drug in single-dose groups were an increase in serum alanine transaminase (ALT), γ-glutamyl transpeptidase, blood urea nitrogen, total bilirubin and skin rash. The numbers of adverse events judged to be possibly related to the drug were 2/18 in the 400 mg, 2/18 in the 800 mg, 1/8 in the 1200 mg, and none in the 200 or 1600 mg dose groups. In the multiple-dose studies, an increased serum ALT and aspartate transaminase (AST) was found in one subject after 7 days of administration of the drug. All serum biochemistry returned to normal levels and skin rash resolved after 7 days without any special treatment. CONCLUSION: Bismuthyl ecabet was shown to be safe and well tolerated in healthy Chinese subjects. The oral dosing regimen selected for subsequent phase II/III clinical trials was 800 mg twice daily.


Asunto(s)
Abietanos/efectos adversos , Antiulcerosos/efectos adversos , Bismuto/efectos adversos , Nitratos/efectos adversos , Abietanos/administración & dosificación , Abietanos/química , Administración Oral , Adulto , Antiulcerosos/administración & dosificación , Antiulcerosos/química , Bismuto/administración & dosificación , Bismuto/química , China , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Nitratos/administración & dosificación , Nitratos/química , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...